DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,616 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,339,983 | -4.8% | 13,462 | -7.9% | 0.06% | +1.6% |
| Q2 2023 | $3,508,594 | -37.2% | 14,619 | -34.0% | 0.06% | -41.1% |
| Q1 2023 | $5,582,490 | -9.8% | 22,149 | -5.0% | 0.11% | -15.7% |
| Q4 2022 | $6,186,966 | +30.8% | 23,310 | +27.3% | 0.13% | +25.7% |
| Q3 2022 | $4,730,000 | +0.9% | 18,314 | -1.0% | 0.10% | +6.3% |
| Q2 2022 | $4,690,000 | -13.0% | 18,500 | +0.7% | 0.10% | +8.0% |
| Q1 2022 | $5,389,000 | -17.6% | 18,373 | -7.6% | 0.09% | -11.1% |
| Q4 2021 | $6,542,000 | +7.4% | 19,884 | -0.6% | 0.10% | +5.3% |
| Q3 2021 | $6,091,000 | +10.1% | 20,008 | -2.9% | 0.09% | +13.3% |
| Q2 2021 | $5,532,000 | +15.6% | 20,614 | -3.1% | 0.08% | +5.1% |
| Q1 2021 | $4,786,000 | -28.4% | 21,265 | -29.4% | 0.08% | -34.2% |
| Q4 2020 | $6,689,000 | +27.7% | 30,112 | +23.8% | 0.12% | +16.5% |
| Q3 2020 | $5,239,000 | +18.9% | 24,330 | -2.4% | 0.10% | +8.4% |
| Q2 2020 | $4,408,000 | +46.1% | 24,927 | +14.3% | 0.10% | +18.8% |
| Q1 2020 | $3,018,000 | -49.7% | 21,805 | -44.2% | 0.08% | -36.5% |
| Q4 2019 | $5,996,000 | +2.8% | 39,064 | -3.2% | 0.13% | -1.6% |
| Q3 2019 | $5,830,000 | -12.1% | 40,364 | -13.1% | 0.13% | -14.7% |
| Q2 2019 | $6,635,000 | +9.4% | 46,423 | +1.1% | 0.15% | +4.2% |
| Q1 2019 | $6,065,000 | +19.7% | 45,940 | -6.5% | 0.14% | 0.0% |
| Q4 2018 | $5,065,000 | -8.8% | 49,119 | -3.9% | 0.14% | +4.3% |
| Q3 2018 | $5,554,000 | -16.1% | 51,109 | -23.8% | 0.14% | -31.0% |
| Q2 2018 | $6,620,000 | +7.0% | 67,089 | +6.1% | 0.20% | -13.4% |
| Q1 2018 | $6,189,000 | -5.1% | 63,215 | -10.0% | 0.23% | -5.3% |
| Q4 2017 | $6,523,000 | +5.9% | 70,273 | -2.1% | 0.24% | +9.4% |
| Q3 2017 | $6,160,000 | +1.1% | 71,814 | -0.5% | 0.22% | +6.7% |
| Q2 2017 | $6,093,000 | -8.1% | 72,196 | -6.9% | 0.21% | -13.3% |
| Q1 2017 | $6,632,000 | +10.2% | 77,545 | +0.3% | 0.24% | -1.6% |
| Q4 2016 | $6,020,000 | -0.2% | 77,333 | +0.5% | 0.24% | -7.2% |
| Q3 2016 | $6,033,000 | -26.2% | 76,965 | -5.0% | 0.26% | -27.7% |
| Q2 2016 | $8,180,000 | +8.7% | 80,988 | +2.0% | 0.36% | -0.8% |
| Q1 2016 | $7,528,000 | +0.2% | 79,363 | -1.9% | 0.37% | -2.4% |
| Q4 2015 | $7,514,000 | +14.1% | 80,903 | +4.7% | 0.38% | +9.9% |
| Q3 2015 | $6,586,000 | -4.6% | 77,286 | -4.1% | 0.34% | +9.6% |
| Q2 2015 | $6,901,000 | -13.7% | 80,626 | -14.4% | 0.31% | -14.0% |
| Q1 2015 | $7,998,000 | -0.7% | 94,199 | +0.2% | 0.36% | -4.5% |
| Q4 2014 | $8,055,000 | +17.1% | 93,982 | +3.8% | 0.38% | +12.1% |
| Q3 2014 | $6,878,000 | -2.6% | 90,521 | +0.9% | 0.34% | -4.5% |
| Q2 2014 | $7,060,000 | +3.2% | 89,671 | -1.7% | 0.36% | -4.6% |
| Q1 2014 | $6,843,000 | -0.3% | 91,239 | +2.7% | 0.37% | +9.7% |
| Q4 2013 | $6,861,000 | +10.7% | 88,876 | -0.6% | 0.34% | +1.8% |
| Q3 2013 | $6,198,000 | +11.3% | 89,405 | +1.6% | 0.33% | +7.4% |
| Q2 2013 | $5,570,000 | – | 87,988 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |